SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (40)7/26/1999 11:21:00 PM
From: Mike McFarland  Read Replies (1) | Respond to of 427
 
This thread has rapidly moved to the top
postion on the Hot Thread list today.
Does that suggest to anybody that there are
wandering packs of dogs looking for targets
on which to go short, or could this be a
general interest in biotech and folks are
merely bookmarking the new thread?

I wonder if a sector rotation out of the big cap
techs and internuts will make biotech the new leader
for this market...or all we all going to suffer as
a general market correction ensues.

Slosh then hunker down...or will the slosh be after
a general market correction?



To: scaram(o)uche who wrote (40)7/26/1999 11:23:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 427
 
MEDI.... short 12.9K shares on 9/30 (at split-adjusted $32.40/share), covered by 3/31/99.

Heh, heh, heh.

I have long believed that there are collaborating funds out there, shorting biotechs. I never expected to run across one that was so damn blind to what they are doing.

Like Franklin Templeton, Prudent Bear, and Jim Cramer's fund, these guys had to write a "sorry about our dismal performance" letter to their investors. Why do the investors continue to assume that the fund managers know their business? Why are these clowns out willy-nilly shorting biotechs at a point where the sector has been beaten on to absurdity?

(a) no brains
(b) no brains
(c) no brains, or
(d) no brains

(multiple choice)